Endo USA, Inc., Malvern, PA. EIN 93-4789629. Annual reports 2009–2024. Also filed as Endo Pharmaceuticals Inc.; Endo Health Solutions Inc.; Endo Health Solution Inc.
Endo USA, Inc. has 2 active retirement plans on file. The largest is the Endo Savings and Investment Plan, with 3,155 participants and $541 million in assets in 2024. Schwab is its recordkeeper. No traditional pension plan appears in Endo USA's filings since 2009.
Active. The plan filed its annual report for the 2024 plan year.
Active. The plan filed its annual report for the 2023 plan year.
Plans merged into this one: Par Pharmaceutical, Inc. Retirement Savings Plan (2016); Ams Savings & Investment Plan (2012); Qualitest Pharmaceuticals 401(k) Plan (2011).
Earlier sponsors: Endo Pharmaceuticals Inc. (2009–2013); Endo Health Solutions Inc. (2014–2022); Endo Health Solution Inc. (2018).
Earlier plan names: Endo Pharmaceuticals Savings and Investment Plan.
| Plan year | Participants | Net assets | Recordkeeper |
|---|---|---|---|
| 2023 | 3,307 | $492 million | Schwab |
| 2022 | 3,560 | $434 million | Schwab |
| 2021 | 3,881 | $565 million | Schwab |
| 2020 | 3,978 | $517 million | Schwab |
| 2019 | 4,108 | $452 million | Schwab |
| 2018 | 4,261 | $381 million | Schwab |
| 2017 | 6,526 | $441 million | Schwab |
| 2016 | 4,117 | $294 million | Schwab |
| 2015 | 4,748 | $312 million | Schwab |
| 2014 | 5,169 | $357 million | Schwab |
| 2013 | 5,055 | $375 million | Schwab |
| 2012 | 5,029 | $201 million | Schwab |
| 2011 | 2,247 | $143 million | Schwab |
| 2010 | 1,610 | $110 million | Principal |
| 2009 | 1,960 | $89.2 million | Principal |
Sources: U.S. Department of Labor, Form 5500 datasets and PBGC trusteed plans. How we read them.